News – Page 71 – Endpoints News

Novartis bolsters Fabhalta data in competition with AstraZeneca

6 months ago

National Resilience to cut 105 employees at Florida site as new CEO takes over

6 months ago

Teva to divest business venture in Japan; Layoffs at Rome Therapeutics

6 months ago

UK’s local vaccine production stymied by budget cuts, government committee says

6 months ago

After switching regulatory plans, AstraZeneca and Daiichi report pooled ADC data in mutant lung cancer

6 months ago

Mark Alles’ ADC bet TORL poaches J&J medical exec; Samsung Bioepis makes historic CEO appointment

6 months ago

BioNTech, DualityBio offer first glimpse at partnered ADC in solid tumors

6 months ago

Merus receives FDA accelerated approval to treat NRG1+ cancers

6 months ago

Lilly continues to expand its empire of GLP-1 factories with new $3B buildout

6 months ago

USPTO withdraws proposed patent rule criticized by pharma industry

6 months ago

After UnitedHealthcare CEO killing, healthcare industry faces a new security reality

6 months ago

FDA spells out new expedited withdrawal procedures for accelerated approvals

6 months ago

Imfinzi snags another FDA nod to treat lung cancer, this time for limited-stage SCLC

6 months ago

Biosecure compromise could add executive review process for named companies, sources say

6 months ago

Amgen deepens roots in North Carolina with latest $1B factory build

6 months ago

Protara’s stock nearly doubles as biotech divulges new bladder cancer data

6 months ago

Eliav Barr defends Merck's LaNova deal, but cautions VEGF bispecifics have yet to deliver mature data

6 months ago

National Resilience's new CEO; Moderna opens Australian manufacturing site

6 months ago

Genmab licenses second monoclonal antibody from Scancell

6 months ago

UK to limit access to Lilly’s Zepbound; VivaVision’s positive Phase 2

6 months ago

GSK's third new pact of the week focuses on Alzheimer's with startup Muna Therapeutics

6 months ago

Nuvig raises $161M as it prepares for Phase 2 study in hot autoimmune field

6 months ago

CG Oncology’s bladder cancer treatment shows durability potential in Phase 3

6 months ago

GSK extends Shingrix pact in China but for less money, adds RSV vaccine deal

6 months ago

First page Previous page 68 69 707172 73 74 Next page Last page